VEGF-A drugs for Wet Age-Related Macular Degeneration
12 tracked VEGF-A drugs in the Wet Age-Related Macular Degeneration race. The class explanation lives on the VEGF-A page; the full indication pipeline across every mechanism is on the Wet Age-Related Macular Degeneration page.
11 approved / phase 41 Phase 3
Head-to-head evidence: Aflibercept vs Brolucizumab-Dbll · Aflibercept vs Ranibizumab · Aflibercept vs Tarcocimab tedromer · Aflibercept vs aflibercept-ayyh (Pavblu) · Aflibercept vs aflibercept-boav (Eydenzelt) · Aflibercept vs aflibercept-jbvf (Yesafili)